Acceleron Pharma to Host Fourth Quarter and Year Ended 2015 Financial Results
18 Febrero 2016 - 6:00AM
Business Wire
Conference Call and Webcast on February 25,
2016
Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage
biopharmaceutical company focused on the discovery, development and
commercialization of novel therapeutic candidates that regulate
cellular growth and repair, today announced that the Company will
host a conference call and live webcast on Thursday, February 25,
2016, at 8:00 AM (EST) to report its fourth quarter and year ended
2015 financial results and provide a corporate update.
To participate by teleconference, please dial 877-312-5848
(domestic) or 253-237-1155 (international) and refer to the
Acceleron Earnings Call. To access the live webcast, please select
“Events & Presentations” in the Investors & Media section
of the Company’s website (www.acceleronpharma.com) at least 10
minutes beforehand to ensure time for any downloads that may be
required.
An archived webcast recording will be available on the Acceleron
website approximately two hours after the event.
About Acceleron
Acceleron is a clinical stage biopharmaceutical company focused
on the discovery, development and commercialization of novel
therapeutic candidates that regulate cellular growth and repair.
The company is a leader in understanding the biology of the
Transforming Growth Factor-Beta protein superfamily, a large and
diverse group of molecules that are key regulators in the growth
and repair of tissues throughout the human body, and in targeting
these pathways to develop important new medicines. Acceleron has
built a highly productive R&D platform that has generated
innovative clinical and preclinical protein therapeutic candidates
with novel mechanisms of action. These protein therapeutic
candidates have the potential to significantly improve clinical
outcomes for patients with cancer and rare diseases.
For more information, please visit www.acceleronpharma.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160218005234/en/
Acceleron PharmaTodd James, 617-649-9393Senior Director,
Investor Relations and Corporate CommunicationsorMedia:BMC
Communications LLCBrad Miles, 646-513-3125
Acceleron Pharma (NASDAQ:XLRN)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Acceleron Pharma (NASDAQ:XLRN)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024
Real-Time news about Acceleron Pharma Inc (NASDAQ): 0 recent articles
Más de Acceleron Pharma Inc. (MM) Artículos de Noticias